The European Parliament has approved a pharmaceutical trade agreement with Israel after two years of attempts by the Palestinian Solidarity Campaign to block the partnership.
The Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA), simplifying sales of Israeli pharmaceuticals in the European Union, passed Tuesday by 379-230.
The measure recognizes Israeli pharmaceutical standards as equal to those of Europe. It was approved by the European council in March 2010, but its implementation was thwarted by pro-Palestinian organizations who sought to foil Israel’s entry into the European market.
About the Author: Malkah Fleisher is a graduate of Cardozo Law School in New York City. She is an editor/staff writer at JewishPress.com and co-hosts a weekly Israeli FM radio show. Malkah lives with her husband and two children on the Mount of Olives in Jerusalem.
If you don't see your comment after publishing it, refresh the page.
Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.
If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.